BEAGLE
2022
Artificial Intelligence-Guided Screening for Atrial Fibrillation Using Electrocardiogram During Sinus Rhythm: a Prospective Non-Randomised Interventional Trial
In 1,003 patients with stroke risk factors and no known atrial fibrillation, AI-ECG risk stratification followed by ambulatory rhythm monitoring increased detection of new atrial fibrillation compared with propensity-matched usual care.
Result
Primary endpoint: Newly diagnosed atrial fibrillation
AF detected in 7.6% (48/633) of AI-high-risk vs 1.6% (6/370) of low-risk patients (OR 4.98, 95% CI 2.11–11.75; P=0.0002); vs propensity-matched usual care, detection 10.6% vs 3.6% in the high-risk group (P<0.0001) and 2.4% vs 0.9% in the low-risk group (P=0.12) over a median 9.9 months.
- Subtopic
- Atrial fibrillation
- Design
- Prospective, non-randomised interventional trial with propensity-matched real-world controls, USA
- Relevance
- Supporting: context rather than must-know.
- Source
- Noseworthy PA, et al. Lancet. 2022;400(10359):1206-1212.doi 10.1016/S0140-6736(22)01637-3
Discussion & critique
Showed that an AI read of a sinus-rhythm ECG can focus AF screening on the patients most likely to have it, a rationale later applied within VITAL-AF. Non-randomised: the usual-care comparison was built by propensity matching from eligible but unenrolled patients, and the endpoint is AF detection rather than stroke prevention, so whether AF found this way benefits from anticoagulation is untested.